Global Drugs for HAE Market Growth 2026-2032
The global Drugs for HAE market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Drugs for Hereditary Angioedema (HAE) are treatments aimed at managing and preventing the recurrent swelling attacks caused by a deficiency or dysfunction of C1 esterase inhibitor (C1-INH). Key therapies include C1-INH replacement (e.g., Berinert, Haegarda), kallikrein inhibitors (e.g., Ecallantide) to block bradykinin production, and bradykinin B2 receptor antagonists (e.g., Icatibant) to stop bradykinin from causing swelling.
United States market for Drugs for HAE is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Drugs for HAE is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Drugs for HAE is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Drugs for HAE players cover Takeda Pharmaceuticals, BioCryst Pharmaceuticals, CSL Behring, Pharming Healthcare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Drugs for HAE Industry Forecast? looks at past sales and reviews total world Drugs for HAE sales in 2025, providing a comprehensive analysis by region and market sector of projected Drugs for HAE sales for 2026 through 2032. With Drugs for HAE sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drugs for HAE industry.
This Insight Report provides a comprehensive analysis of the global Drugs for HAE landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drugs for HAE portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Drugs for HAE market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drugs for HAE and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drugs for HAE.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for HAE market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Drugs for HAE market?
What factors are driving Drugs for HAE market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drugs for HAE market opportunities vary by end market size?
How does Drugs for HAE break out by Type, by Application?
Drugs for Hereditary Angioedema (HAE) are treatments aimed at managing and preventing the recurrent swelling attacks caused by a deficiency or dysfunction of C1 esterase inhibitor (C1-INH). Key therapies include C1-INH replacement (e.g., Berinert, Haegarda), kallikrein inhibitors (e.g., Ecallantide) to block bradykinin production, and bradykinin B2 receptor antagonists (e.g., Icatibant) to stop bradykinin from causing swelling.
United States market for Drugs for HAE is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Drugs for HAE is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Drugs for HAE is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Drugs for HAE players cover Takeda Pharmaceuticals, BioCryst Pharmaceuticals, CSL Behring, Pharming Healthcare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Drugs for HAE Industry Forecast? looks at past sales and reviews total world Drugs for HAE sales in 2025, providing a comprehensive analysis by region and market sector of projected Drugs for HAE sales for 2026 through 2032. With Drugs for HAE sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drugs for HAE industry.
This Insight Report provides a comprehensive analysis of the global Drugs for HAE landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drugs for HAE portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Drugs for HAE market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drugs for HAE and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drugs for HAE.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for HAE market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- C1 Esterase Inhibitors
- Kallikrein Inhibitors
- Bradykinin Receptor Antagonist
- Hospital and Clinic
- Pharmacy
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Takeda Pharmaceuticals
- BioCryst Pharmaceuticals
- CSL Behring
- Pharming Healthcare
What is the 10-year outlook for the global Drugs for HAE market?
What factors are driving Drugs for HAE market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drugs for HAE market opportunities vary by end market size?
How does Drugs for HAE break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drugs for HAE Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Drugs for HAE by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Drugs for HAE by Country/Region, 2021, 2025 & 2032
2.2 Drugs for HAE Segment by Type
2.2.1 C1 Esterase Inhibitors
2.2.2 Kallikrein Inhibitors
2.2.3 Bradykinin Receptor Antagonist
2.2.4 Drugs for HAE Sales by Type
2.2.4.1 Global Drugs for HAE Sales Market Share by Type (2021-2026)
2.2.4.2 Global Drugs for HAE Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Drugs for HAE Sale Price by Type (2021-2026)
2.3 Drugs for HAE Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Pharmacy
2.3.3 Other
2.3.4 Drugs for HAE Sales by Application
2.3.4.1 Global Drugs for HAE Sale Market Share by Application (2021-2026)
2.3.4.2 Global Drugs for HAE Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Drugs for HAE Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Drugs for HAE Breakdown Data by Company
3.1.1 Global Drugs for HAE Annual Sales by Company (2021-2026)
3.1.2 Global Drugs for HAE Sales Market Share by Company (2021-2026)
3.2 Global Drugs for HAE Annual Revenue by Company (2021-2026)
3.2.1 Global Drugs for HAE Revenue by Company (2021-2026)
3.2.2 Global Drugs for HAE Revenue Market Share by Company (2021-2026)
3.3 Global Drugs for HAE Sale Price by Company
3.4 Key Manufacturers Drugs for HAE Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drugs for HAE Product Location Distribution
3.4.2 Players Drugs for HAE Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DRUGS FOR HAE BY GEOGRAPHIC REGION
4.1 World Historic Drugs for HAE Market Size by Geographic Region (2021-2026)
4.1.1 Global Drugs for HAE Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Drugs for HAE Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Drugs for HAE Market Size by Country/Region (2021-2026)
4.2.1 Global Drugs for HAE Annual Sales by Country/Region (2021-2026)
4.2.2 Global Drugs for HAE Annual Revenue by Country/Region (2021-2026)
4.3 Americas Drugs for HAE Sales Growth
4.4 APAC Drugs for HAE Sales Growth
4.5 Europe Drugs for HAE Sales Growth
4.6 Middle East & Africa Drugs for HAE Sales Growth
5 AMERICAS
5.1 Americas Drugs for HAE Sales by Country
5.1.1 Americas Drugs for HAE Sales by Country (2021-2026)
5.1.2 Americas Drugs for HAE Revenue by Country (2021-2026)
5.2 Americas Drugs for HAE Sales by Type (2021-2026)
5.3 Americas Drugs for HAE Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs for HAE Sales by Region
6.1.1 APAC Drugs for HAE Sales by Region (2021-2026)
6.1.2 APAC Drugs for HAE Revenue by Region (2021-2026)
6.2 APAC Drugs for HAE Sales by Type (2021-2026)
6.3 APAC Drugs for HAE Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drugs for HAE by Country
7.1.1 Europe Drugs for HAE Sales by Country (2021-2026)
7.1.2 Europe Drugs for HAE Revenue by Country (2021-2026)
7.2 Europe Drugs for HAE Sales by Type (2021-2026)
7.3 Europe Drugs for HAE Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drugs for HAE by Country
8.1.1 Middle East & Africa Drugs for HAE Sales by Country (2021-2026)
8.1.2 Middle East & Africa Drugs for HAE Revenue by Country (2021-2026)
8.2 Middle East & Africa Drugs for HAE Sales by Type (2021-2026)
8.3 Middle East & Africa Drugs for HAE Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drugs for HAE
10.3 Manufacturing Process Analysis of Drugs for HAE
10.4 Industry Chain Structure of Drugs for HAE
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drugs for HAE Distributors
11.3 Drugs for HAE Customer
12 WORLD FORECAST REVIEW FOR DRUGS FOR HAE BY GEOGRAPHIC REGION
12.1 Global Drugs for HAE Market Size Forecast by Region
12.1.1 Global Drugs for HAE Forecast by Region (2027-2032)
12.1.2 Global Drugs for HAE Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Drugs for HAE Forecast by Type (2027-2032)
12.7 Global Drugs for HAE Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Takeda Pharmaceuticals
13.1.1 Takeda Pharmaceuticals Company Information
13.1.2 Takeda Pharmaceuticals Drugs for HAE Product Portfolios and Specifications
13.1.3 Takeda Pharmaceuticals Drugs for HAE Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Takeda Pharmaceuticals Main Business Overview
13.1.5 Takeda Pharmaceuticals Latest Developments
13.2 BioCryst Pharmaceuticals
13.2.1 BioCryst Pharmaceuticals Company Information
13.2.2 BioCryst Pharmaceuticals Drugs for HAE Product Portfolios and Specifications
13.2.3 BioCryst Pharmaceuticals Drugs for HAE Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 BioCryst Pharmaceuticals Main Business Overview
13.2.5 BioCryst Pharmaceuticals Latest Developments
13.3 CSL Behring
13.3.1 CSL Behring Company Information
13.3.2 CSL Behring Drugs for HAE Product Portfolios and Specifications
13.3.3 CSL Behring Drugs for HAE Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 CSL Behring Main Business Overview
13.3.5 CSL Behring Latest Developments
13.4 Pharming Healthcare
13.4.1 Pharming Healthcare Company Information
13.4.2 Pharming Healthcare Drugs for HAE Product Portfolios and Specifications
13.4.3 Pharming Healthcare Drugs for HAE Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Pharming Healthcare Main Business Overview
13.4.5 Pharming Healthcare Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drugs for HAE Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Drugs for HAE by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Drugs for HAE by Country/Region, 2021, 2025 & 2032
2.2 Drugs for HAE Segment by Type
2.2.1 C1 Esterase Inhibitors
2.2.2 Kallikrein Inhibitors
2.2.3 Bradykinin Receptor Antagonist
2.2.4 Drugs for HAE Sales by Type
2.2.4.1 Global Drugs for HAE Sales Market Share by Type (2021-2026)
2.2.4.2 Global Drugs for HAE Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Drugs for HAE Sale Price by Type (2021-2026)
2.3 Drugs for HAE Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Pharmacy
2.3.3 Other
2.3.4 Drugs for HAE Sales by Application
2.3.4.1 Global Drugs for HAE Sale Market Share by Application (2021-2026)
2.3.4.2 Global Drugs for HAE Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Drugs for HAE Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Drugs for HAE Breakdown Data by Company
3.1.1 Global Drugs for HAE Annual Sales by Company (2021-2026)
3.1.2 Global Drugs for HAE Sales Market Share by Company (2021-2026)
3.2 Global Drugs for HAE Annual Revenue by Company (2021-2026)
3.2.1 Global Drugs for HAE Revenue by Company (2021-2026)
3.2.2 Global Drugs for HAE Revenue Market Share by Company (2021-2026)
3.3 Global Drugs for HAE Sale Price by Company
3.4 Key Manufacturers Drugs for HAE Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drugs for HAE Product Location Distribution
3.4.2 Players Drugs for HAE Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DRUGS FOR HAE BY GEOGRAPHIC REGION
4.1 World Historic Drugs for HAE Market Size by Geographic Region (2021-2026)
4.1.1 Global Drugs for HAE Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Drugs for HAE Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Drugs for HAE Market Size by Country/Region (2021-2026)
4.2.1 Global Drugs for HAE Annual Sales by Country/Region (2021-2026)
4.2.2 Global Drugs for HAE Annual Revenue by Country/Region (2021-2026)
4.3 Americas Drugs for HAE Sales Growth
4.4 APAC Drugs for HAE Sales Growth
4.5 Europe Drugs for HAE Sales Growth
4.6 Middle East & Africa Drugs for HAE Sales Growth
5 AMERICAS
5.1 Americas Drugs for HAE Sales by Country
5.1.1 Americas Drugs for HAE Sales by Country (2021-2026)
5.1.2 Americas Drugs for HAE Revenue by Country (2021-2026)
5.2 Americas Drugs for HAE Sales by Type (2021-2026)
5.3 Americas Drugs for HAE Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs for HAE Sales by Region
6.1.1 APAC Drugs for HAE Sales by Region (2021-2026)
6.1.2 APAC Drugs for HAE Revenue by Region (2021-2026)
6.2 APAC Drugs for HAE Sales by Type (2021-2026)
6.3 APAC Drugs for HAE Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drugs for HAE by Country
7.1.1 Europe Drugs for HAE Sales by Country (2021-2026)
7.1.2 Europe Drugs for HAE Revenue by Country (2021-2026)
7.2 Europe Drugs for HAE Sales by Type (2021-2026)
7.3 Europe Drugs for HAE Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drugs for HAE by Country
8.1.1 Middle East & Africa Drugs for HAE Sales by Country (2021-2026)
8.1.2 Middle East & Africa Drugs for HAE Revenue by Country (2021-2026)
8.2 Middle East & Africa Drugs for HAE Sales by Type (2021-2026)
8.3 Middle East & Africa Drugs for HAE Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drugs for HAE
10.3 Manufacturing Process Analysis of Drugs for HAE
10.4 Industry Chain Structure of Drugs for HAE
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drugs for HAE Distributors
11.3 Drugs for HAE Customer
12 WORLD FORECAST REVIEW FOR DRUGS FOR HAE BY GEOGRAPHIC REGION
12.1 Global Drugs for HAE Market Size Forecast by Region
12.1.1 Global Drugs for HAE Forecast by Region (2027-2032)
12.1.2 Global Drugs for HAE Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Drugs for HAE Forecast by Type (2027-2032)
12.7 Global Drugs for HAE Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Takeda Pharmaceuticals
13.1.1 Takeda Pharmaceuticals Company Information
13.1.2 Takeda Pharmaceuticals Drugs for HAE Product Portfolios and Specifications
13.1.3 Takeda Pharmaceuticals Drugs for HAE Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Takeda Pharmaceuticals Main Business Overview
13.1.5 Takeda Pharmaceuticals Latest Developments
13.2 BioCryst Pharmaceuticals
13.2.1 BioCryst Pharmaceuticals Company Information
13.2.2 BioCryst Pharmaceuticals Drugs for HAE Product Portfolios and Specifications
13.2.3 BioCryst Pharmaceuticals Drugs for HAE Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 BioCryst Pharmaceuticals Main Business Overview
13.2.5 BioCryst Pharmaceuticals Latest Developments
13.3 CSL Behring
13.3.1 CSL Behring Company Information
13.3.2 CSL Behring Drugs for HAE Product Portfolios and Specifications
13.3.3 CSL Behring Drugs for HAE Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 CSL Behring Main Business Overview
13.3.5 CSL Behring Latest Developments
13.4 Pharming Healthcare
13.4.1 Pharming Healthcare Company Information
13.4.2 Pharming Healthcare Drugs for HAE Product Portfolios and Specifications
13.4.3 Pharming Healthcare Drugs for HAE Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Pharming Healthcare Main Business Overview
13.4.5 Pharming Healthcare Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drugs for HAE Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Drugs for HAE Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of C1 Esterase Inhibitors
Table 4. Major Players of Kallikrein Inhibitors
Table 5. Major Players of Bradykinin Receptor Antagonist
Table 6. Global Drugs for HAE Sales by Type (2021-2026) & (K Units)
Table 7. Global Drugs for HAE Sales Market Share by Type (2021-2026)
Table 8. Global Drugs for HAE Revenue by Type (2021-2026) & ($ million)
Table 9. Global Drugs for HAE Revenue Market Share by Type (2021-2026)
Table 10. Global Drugs for HAE Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Drugs for HAE Sale by Application (2021-2026) & (K Units)
Table 12. Global Drugs for HAE Sale Market Share by Application (2021-2026)
Table 13. Global Drugs for HAE Revenue by Application (2021-2026) & ($ million)
Table 14. Global Drugs for HAE Revenue Market Share by Application (2021-2026)
Table 15. Global Drugs for HAE Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Drugs for HAE Sales by Company (2021-2026) & (K Units)
Table 17. Global Drugs for HAE Sales Market Share by Company (2021-2026)
Table 18. Global Drugs for HAE Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Drugs for HAE Revenue Market Share by Company (2021-2026)
Table 20. Global Drugs for HAE Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Drugs for HAE Producing Area Distribution and Sales Area
Table 22. Players Drugs for HAE Products Offered
Table 23. Drugs for HAE Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Drugs for HAE Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Drugs for HAE Sales Market Share Geographic Region (2021-2026)
Table 28. Global Drugs for HAE Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Drugs for HAE Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Drugs for HAE Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Drugs for HAE Sales Market Share by Country/Region (2021-2026)
Table 32. Global Drugs for HAE Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Drugs for HAE Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Drugs for HAE Sales by Country (2021-2026) & (K Units)
Table 35. Americas Drugs for HAE Sales Market Share by Country (2021-2026)
Table 36. Americas Drugs for HAE Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Drugs for HAE Sales by Type (2021-2026) & (K Units)
Table 38. Americas Drugs for HAE Sales by Application (2021-2026) & (K Units)
Table 39. APAC Drugs for HAE Sales by Region (2021-2026) & (K Units)
Table 40. APAC Drugs for HAE Sales Market Share by Region (2021-2026)
Table 41. APAC Drugs for HAE Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Drugs for HAE Sales by Type (2021-2026) & (K Units)
Table 43. APAC Drugs for HAE Sales by Application (2021-2026) & (K Units)
Table 44. Europe Drugs for HAE Sales by Country (2021-2026) & (K Units)
Table 45. Europe Drugs for HAE Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Drugs for HAE Sales by Type (2021-2026) & (K Units)
Table 47. Europe Drugs for HAE Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Drugs for HAE Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Drugs for HAE Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Drugs for HAE Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Drugs for HAE Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Drugs for HAE
Table 53. Key Market Challenges & Risks of Drugs for HAE
Table 54. Key Industry Trends of Drugs for HAE
Table 55. Drugs for HAE Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Drugs for HAE Distributors List
Table 58. Drugs for HAE Customer List
Table 59. Global Drugs for HAE Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Drugs for HAE Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Drugs for HAE Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Drugs for HAE Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Drugs for HAE Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Drugs for HAE Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Drugs for HAE Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Drugs for HAE Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Drugs for HAE Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Drugs for HAE Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Drugs for HAE Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Drugs for HAE Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Drugs for HAE Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Drugs for HAE Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Takeda Pharmaceuticals Basic Information, Drugs for HAE Manufacturing Base, Sales Area and Its Competitors
Table 74. Takeda Pharmaceuticals Drugs for HAE Product Portfolios and Specifications
Table 75. Takeda Pharmaceuticals Drugs for HAE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Takeda Pharmaceuticals Main Business
Table 77. Takeda Pharmaceuticals Latest Developments
Table 78. BioCryst Pharmaceuticals Basic Information, Drugs for HAE Manufacturing Base, Sales Area and Its Competitors
Table 79. BioCryst Pharmaceuticals Drugs for HAE Product Portfolios and Specifications
Table 80. BioCryst Pharmaceuticals Drugs for HAE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. BioCryst Pharmaceuticals Main Business
Table 82. BioCryst Pharmaceuticals Latest Developments
Table 83. CSL Behring Basic Information, Drugs for HAE Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Behring Drugs for HAE Product Portfolios and Specifications
Table 85. CSL Behring Drugs for HAE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. CSL Behring Main Business
Table 87. CSL Behring Latest Developments
Table 88. Pharming Healthcare Basic Information, Drugs for HAE Manufacturing Base, Sales Area and Its Competitors
Table 89. Pharming Healthcare Drugs for HAE Product Portfolios and Specifications
Table 90. Pharming Healthcare Drugs for HAE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Pharming Healthcare Main Business
Table 92. Pharming Healthcare Latest Developments
Table 1. Drugs for HAE Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Drugs for HAE Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of C1 Esterase Inhibitors
Table 4. Major Players of Kallikrein Inhibitors
Table 5. Major Players of Bradykinin Receptor Antagonist
Table 6. Global Drugs for HAE Sales by Type (2021-2026) & (K Units)
Table 7. Global Drugs for HAE Sales Market Share by Type (2021-2026)
Table 8. Global Drugs for HAE Revenue by Type (2021-2026) & ($ million)
Table 9. Global Drugs for HAE Revenue Market Share by Type (2021-2026)
Table 10. Global Drugs for HAE Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Drugs for HAE Sale by Application (2021-2026) & (K Units)
Table 12. Global Drugs for HAE Sale Market Share by Application (2021-2026)
Table 13. Global Drugs for HAE Revenue by Application (2021-2026) & ($ million)
Table 14. Global Drugs for HAE Revenue Market Share by Application (2021-2026)
Table 15. Global Drugs for HAE Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Drugs for HAE Sales by Company (2021-2026) & (K Units)
Table 17. Global Drugs for HAE Sales Market Share by Company (2021-2026)
Table 18. Global Drugs for HAE Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Drugs for HAE Revenue Market Share by Company (2021-2026)
Table 20. Global Drugs for HAE Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Drugs for HAE Producing Area Distribution and Sales Area
Table 22. Players Drugs for HAE Products Offered
Table 23. Drugs for HAE Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Drugs for HAE Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Drugs for HAE Sales Market Share Geographic Region (2021-2026)
Table 28. Global Drugs for HAE Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Drugs for HAE Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Drugs for HAE Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Drugs for HAE Sales Market Share by Country/Region (2021-2026)
Table 32. Global Drugs for HAE Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Drugs for HAE Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Drugs for HAE Sales by Country (2021-2026) & (K Units)
Table 35. Americas Drugs for HAE Sales Market Share by Country (2021-2026)
Table 36. Americas Drugs for HAE Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Drugs for HAE Sales by Type (2021-2026) & (K Units)
Table 38. Americas Drugs for HAE Sales by Application (2021-2026) & (K Units)
Table 39. APAC Drugs for HAE Sales by Region (2021-2026) & (K Units)
Table 40. APAC Drugs for HAE Sales Market Share by Region (2021-2026)
Table 41. APAC Drugs for HAE Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Drugs for HAE Sales by Type (2021-2026) & (K Units)
Table 43. APAC Drugs for HAE Sales by Application (2021-2026) & (K Units)
Table 44. Europe Drugs for HAE Sales by Country (2021-2026) & (K Units)
Table 45. Europe Drugs for HAE Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Drugs for HAE Sales by Type (2021-2026) & (K Units)
Table 47. Europe Drugs for HAE Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Drugs for HAE Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Drugs for HAE Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Drugs for HAE Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Drugs for HAE Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Drugs for HAE
Table 53. Key Market Challenges & Risks of Drugs for HAE
Table 54. Key Industry Trends of Drugs for HAE
Table 55. Drugs for HAE Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Drugs for HAE Distributors List
Table 58. Drugs for HAE Customer List
Table 59. Global Drugs for HAE Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Drugs for HAE Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Drugs for HAE Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Drugs for HAE Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Drugs for HAE Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Drugs for HAE Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Drugs for HAE Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Drugs for HAE Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Drugs for HAE Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Drugs for HAE Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Drugs for HAE Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Drugs for HAE Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Drugs for HAE Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Drugs for HAE Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Takeda Pharmaceuticals Basic Information, Drugs for HAE Manufacturing Base, Sales Area and Its Competitors
Table 74. Takeda Pharmaceuticals Drugs for HAE Product Portfolios and Specifications
Table 75. Takeda Pharmaceuticals Drugs for HAE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Takeda Pharmaceuticals Main Business
Table 77. Takeda Pharmaceuticals Latest Developments
Table 78. BioCryst Pharmaceuticals Basic Information, Drugs for HAE Manufacturing Base, Sales Area and Its Competitors
Table 79. BioCryst Pharmaceuticals Drugs for HAE Product Portfolios and Specifications
Table 80. BioCryst Pharmaceuticals Drugs for HAE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. BioCryst Pharmaceuticals Main Business
Table 82. BioCryst Pharmaceuticals Latest Developments
Table 83. CSL Behring Basic Information, Drugs for HAE Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Behring Drugs for HAE Product Portfolios and Specifications
Table 85. CSL Behring Drugs for HAE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. CSL Behring Main Business
Table 87. CSL Behring Latest Developments
Table 88. Pharming Healthcare Basic Information, Drugs for HAE Manufacturing Base, Sales Area and Its Competitors
Table 89. Pharming Healthcare Drugs for HAE Product Portfolios and Specifications
Table 90. Pharming Healthcare Drugs for HAE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Pharming Healthcare Main Business
Table 92. Pharming Healthcare Latest Developments
LIST OF FIGURES
Figure 1. Picture of Drugs for HAE
Figure 2. Drugs for HAE Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drugs for HAE Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Drugs for HAE Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Drugs for HAE Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Drugs for HAE Sales Market Share by Country/Region (2025)
Figure 10. Drugs for HAE Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of C1 Esterase Inhibitors
Figure 12. Product Picture of Kallikrein Inhibitors
Figure 13. Product Picture of Bradykinin Receptor Antagonist
Figure 14. Global Drugs for HAE Sales Market Share by Type in 2026
Figure 15. Global Drugs for HAE Revenue Market Share by Type (2021-2026)
Figure 16. Drugs for HAE Consumed in Hospital and Clinic
Figure 17. Global Drugs for HAE Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 18. Drugs for HAE Consumed in Pharmacy
Figure 19. Global Drugs for HAE Market: Pharmacy (2021-2026) & (K Units)
Figure 20. Drugs for HAE Consumed in Other
Figure 21. Global Drugs for HAE Market: Other (2021-2026) & (K Units)
Figure 22. Global Drugs for HAE Sale Market Share by Application (2025)
Figure 23. Global Drugs for HAE Revenue Market Share by Application in 2026
Figure 24. Drugs for HAE Sales by Company in 2026 (K Units)
Figure 25. Global Drugs for HAE Sales Market Share by Company in 2026
Figure 26. Drugs for HAE Revenue by Company in 2026 ($ millions)
Figure 27. Global Drugs for HAE Revenue Market Share by Company in 2026
Figure 28. Global Drugs for HAE Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Drugs for HAE Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Drugs for HAE Sales 2021-2026 (K Units)
Figure 31. Americas Drugs for HAE Revenue 2021-2026 ($ millions)
Figure 32. APAC Drugs for HAE Sales 2021-2026 (K Units)
Figure 33. APAC Drugs for HAE Revenue 2021-2026 ($ millions)
Figure 34. Europe Drugs for HAE Sales 2021-2026 (K Units)
Figure 35. Europe Drugs for HAE Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Drugs for HAE Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Drugs for HAE Revenue 2021-2026 ($ millions)
Figure 38. Americas Drugs for HAE Sales Market Share by Country in 2026
Figure 39. Americas Drugs for HAE Revenue Market Share by Country (2021-2026)
Figure 40. Americas Drugs for HAE Sales Market Share by Type (2021-2026)
Figure 41. Americas Drugs for HAE Sales Market Share by Application (2021-2026)
Figure 42. United States Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Drugs for HAE Sales Market Share by Region in 2026
Figure 47. APAC Drugs for HAE Revenue Market Share by Region (2021-2026)
Figure 48. APAC Drugs for HAE Sales Market Share by Type (2021-2026)
Figure 49. APAC Drugs for HAE Sales Market Share by Application (2021-2026)
Figure 50. China Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 54. India Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Drugs for HAE Sales Market Share by Country in 2026
Figure 58. Europe Drugs for HAE Revenue Market Share by Country (2021-2026)
Figure 59. Europe Drugs for HAE Sales Market Share by Type (2021-2026)
Figure 60. Europe Drugs for HAE Sales Market Share by Application (2021-2026)
Figure 61. Germany Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 62. France Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Drugs for HAE Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Drugs for HAE Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Drugs for HAE Sales Market Share by Application (2021-2026)
Figure 69. Egypt Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Drugs for HAE in 2026
Figure 75. Manufacturing Process Analysis of Drugs for HAE
Figure 76. Industry Chain Structure of Drugs for HAE
Figure 77. Channels of Distribution
Figure 78. Global Drugs for HAE Sales Market Forecast by Region (2027-2032)
Figure 79. Global Drugs for HAE Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Drugs for HAE Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Drugs for HAE Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Drugs for HAE Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Drugs for HAE Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Drugs for HAE
Figure 2. Drugs for HAE Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drugs for HAE Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Drugs for HAE Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Drugs for HAE Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Drugs for HAE Sales Market Share by Country/Region (2025)
Figure 10. Drugs for HAE Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of C1 Esterase Inhibitors
Figure 12. Product Picture of Kallikrein Inhibitors
Figure 13. Product Picture of Bradykinin Receptor Antagonist
Figure 14. Global Drugs for HAE Sales Market Share by Type in 2026
Figure 15. Global Drugs for HAE Revenue Market Share by Type (2021-2026)
Figure 16. Drugs for HAE Consumed in Hospital and Clinic
Figure 17. Global Drugs for HAE Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 18. Drugs for HAE Consumed in Pharmacy
Figure 19. Global Drugs for HAE Market: Pharmacy (2021-2026) & (K Units)
Figure 20. Drugs for HAE Consumed in Other
Figure 21. Global Drugs for HAE Market: Other (2021-2026) & (K Units)
Figure 22. Global Drugs for HAE Sale Market Share by Application (2025)
Figure 23. Global Drugs for HAE Revenue Market Share by Application in 2026
Figure 24. Drugs for HAE Sales by Company in 2026 (K Units)
Figure 25. Global Drugs for HAE Sales Market Share by Company in 2026
Figure 26. Drugs for HAE Revenue by Company in 2026 ($ millions)
Figure 27. Global Drugs for HAE Revenue Market Share by Company in 2026
Figure 28. Global Drugs for HAE Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Drugs for HAE Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Drugs for HAE Sales 2021-2026 (K Units)
Figure 31. Americas Drugs for HAE Revenue 2021-2026 ($ millions)
Figure 32. APAC Drugs for HAE Sales 2021-2026 (K Units)
Figure 33. APAC Drugs for HAE Revenue 2021-2026 ($ millions)
Figure 34. Europe Drugs for HAE Sales 2021-2026 (K Units)
Figure 35. Europe Drugs for HAE Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Drugs for HAE Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Drugs for HAE Revenue 2021-2026 ($ millions)
Figure 38. Americas Drugs for HAE Sales Market Share by Country in 2026
Figure 39. Americas Drugs for HAE Revenue Market Share by Country (2021-2026)
Figure 40. Americas Drugs for HAE Sales Market Share by Type (2021-2026)
Figure 41. Americas Drugs for HAE Sales Market Share by Application (2021-2026)
Figure 42. United States Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Drugs for HAE Sales Market Share by Region in 2026
Figure 47. APAC Drugs for HAE Revenue Market Share by Region (2021-2026)
Figure 48. APAC Drugs for HAE Sales Market Share by Type (2021-2026)
Figure 49. APAC Drugs for HAE Sales Market Share by Application (2021-2026)
Figure 50. China Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 54. India Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Drugs for HAE Sales Market Share by Country in 2026
Figure 58. Europe Drugs for HAE Revenue Market Share by Country (2021-2026)
Figure 59. Europe Drugs for HAE Sales Market Share by Type (2021-2026)
Figure 60. Europe Drugs for HAE Sales Market Share by Application (2021-2026)
Figure 61. Germany Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 62. France Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Drugs for HAE Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Drugs for HAE Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Drugs for HAE Sales Market Share by Application (2021-2026)
Figure 69. Egypt Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Drugs for HAE Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Drugs for HAE in 2026
Figure 75. Manufacturing Process Analysis of Drugs for HAE
Figure 76. Industry Chain Structure of Drugs for HAE
Figure 77. Channels of Distribution
Figure 78. Global Drugs for HAE Sales Market Forecast by Region (2027-2032)
Figure 79. Global Drugs for HAE Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Drugs for HAE Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Drugs for HAE Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Drugs for HAE Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Drugs for HAE Revenue Market Share Forecast by Application (2027-2032)
